Latest news
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:50:20 GMTPacific Biosciences of California, Inc. Stock 12‑Month Price Target Cut to $2.29, Implies 76% Upside - TradingViewTradingView · Thu, 06 Aug 2026 20:24:18 GMTETFs Investing in Pacific Biosciences of California, Inc. Stocks - TradingViewTradingView · Thu, 06 Aug 2026 01:56:07 GMTPacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 22:40:26 GMTPacific Biosciences Q2 adj. loss bigger than estimates on margin pressure - TradingViewTradingView · Wed, 05 Aug 2026 20:42:18 GMTPacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview - TradingViewTradingView · Mon, 03 Aug 2026 22:14:07 GMTPACB5949325 Bond Profile — Key Metrics - TradingViewTradingView · Sun, 02 Aug 2026 00:50:05 GMTPACB5949325 Bond Risk Profile - TradingViewTradingView · Sat, 01 Aug 2026 10:10:00 GMT